XRAD THERAPEUTICS
XRAD THERAPEUTICS
Industry:
Biotechnology Health Care
Founded:
2016-01-01
Address:
New York, New York, United States
Country:
United States
Total Employee:
1+
Status:
Active
Contact:
(917) 809-0858
Total Funding:
498.62 K USD
Similar Organizations
DNX Biotherapeutics
DNX Biotherapeutics is a Biotechnology company.
Primmune Therapeutics
Primmune Therapeutics is a Biotechnology company.
More informations about "XRad Therapeutics"
XRad Therapeutics - Developing Innovative Therapies …
XRad Therapeutics is a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for treating cancer. The company’s lead product, XRD-0394, is currently being evaluated in the clinic. XRD-0394.See details»
XRad Therapeutics - Crunchbase Company Profile & Funding
Organization. XRad Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. XRad Therapeutics is a …See details»
XRad Therapeutics - PitchBook
XRad Therapeutics General Information Description. Operator of a biotechnology company intended to develop dual kinase inhibitors for treating cancer. The company develops dual inhibitors of ataxia-telangiectasia mutated (ATM) and …See details»
XRad Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials
Jul 10, 2023 Explore XRad Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Disease Domain:Neoplasms, Technology Platform ...See details»
XRad Therapeutics - VentureRadar
XRad Therapeutics is a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for treating cancer. The company’s lead candidate, XRD …See details»
XRD-0394 - Drug Targets, Indications, Patents - Synapse - Patsnap
About XRad Therapeutics XRad Therapeutics is a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for treating cancer. The company’s lead …See details»
XRad Therapeutics Inc Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for XRad Therapeutics Inc of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
XRad Therapeutics - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 19, 2017: Seed Round - …See details»
Xrad Therapeutics, Inc. in New Lenox IL - Company Profile
May 17, 2016 Xrad Therapeutics, Inc. Overview. Xrad Therapeutics, Inc. filed as a Foreign Business Corporation in the State of New York on Tuesday, May 17, 2016 and is …See details»
XRD-0394 and Palliative radiotherapy in Metastasis and ... - ICH GCP
Jul 11, 2021 XRad Therapeutics Inc Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported …See details»
XRAD THERAPEUTICS, INC.. Orlando, FL - BisProfiles
Dec 17, 2021 XRAD THERAPEUTICS, INC. is an Active company incorporated on December 17, 2021 with the registered number F21000007244. This Foreign for Profit company is …See details»
XRD-0394 by XRad Therapeutics for Solid Tumor: Likelihood of …
Aug 28, 2024 XRad Therapeutics overview. XRad Therapeutics, Inc. operates in the healthcare industry focusing on biotechnology business. For a complete picture of XRD-0394’s drug …See details»
CRO Support for XRad Therapeutics | Catalyst Clinical Research
Manchester, U.K., 25 August 2021 – The dosing of the first patient into US-based XRad Therapeutics’ Phase 1a study of XRD-0394 in metastatic, locally advanced, or recurrent solid …See details»
XRD 0394 - AdisInsight - Springer
Originator XRad Therapeutics Class Antineoplastics; Radioprotectives; Small molecules Mechanism of Action ... If your organization has a subscription, there are several access …See details»
XRad Therapeutics Announces First Patient Dosed in Phase 1a …
DURHAM, NC, August 24, 2021 – XRad Therapeutics, a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for treating cancer, …See details»
XRD-0394 / XRad Therap - LARVOL DELTA - delta.larvol.com
News for XRD-0394 / XRad Therap. XRad Therapeutics Announces First Patient Dosed in Phase 1a Clinical Trial of XRD-0394 for Metastatic, Locally-Advanced or Recurrent Solid Tumors …See details»
XRad Therapeutics Announces First Patient Dosed in Phase 1a …
Aug 25, 2021 Detailed price information for Medovex Corp (MDVX) from The Globe and Mail including charting and trades.See details»
XRad Therapeutics Announces First Patient Dosed in Phase 1a …
DURHAM, N.C., Aug. 25, 2021 (GLOBE NEWSWIRE) -- XRad Therapeutics, a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for …See details»
Enhancing radiotherapy response via intratumoral injection of the …
Jan 4, 2024 The laboratory of DGK received funding from Xrad Therapeutics, Merck, Bristol-Myers Squibb, but this did not support the research described in this manuscript. DGK …See details»
XRad Therapeutics Announces First Patient Dosed in Phase 1a
Aug 25, 2021 XRad Therapeutics is a privately-held, clinical stage biopharmaceutical company focused on developing dual kinase inhibitors for treating cancer. The company’s lead …See details»